FDA Wants Authority To Help Curb Demand-Driven Drug Shortages

FDA is asking Congress for authority to require drug makers to report spikes in demand for their products, in a bid to curb demand-driven shortages -- an issue that has become more prevalent since the start of the COVID-19 pandemic and has been exacerbated by a recent convergence of viruses, including coronavirus, flu and respiratory syncytial virus. FDA included the request with several other legislative proposals it hopes to see included in the Pandemic and All-Hazards Preparedness Act that must...